DeepCurrents Investment Group LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 38 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DeepCurrents Investment Group LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$49,938,921
+38.9%
39,528,000
+163.5%
2.17%
+52.9%
Q2 2023$35,954,355
+38.8%
15,000,000
-14.5%
1.42%
+37.4%
Q2 2022$25,898,000
-40.6%
17,550,000
-36.3%
1.03%
-23.8%
Q1 2022$43,604,000
+44.9%
27,550,000
+37.2%
1.36%
+45.1%
Q4 2021$30,085,000
+62.4%
20,079,000
+33.2%
0.94%
+69.1%
Q3 2021$18,525,000
-22.1%
15,079,000
+18.3%
0.55%
-22.3%
Q2 2021$23,782,000
+382.1%
12,750,000
+183.3%
0.71%
+328.9%
Q3 2020$4,933,0004,500,0000.17%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 28,825,000$35,498,0000.69%
DeepCurrents Investment Group LLC 15,079,000$18,525,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 33,996,000$41,869,0000.36%
Weiss Asset Management LP 9,000,000$10,980,0000.28%
SSI INVESTMENT MANAGEMENT LLC 3,418,000$4,192,0000.25%
Baker Brothers Advisors 46,754,000$57,262,0000.25%
MACKAY SHIELDS LLC 15,855,000$19,641,0000.18%
Verition Fund Management LLC 4,310,000$5,350,0000.05%
WESTWOOD HOLDINGS GROUP INC 1,000,000$1,236,0000.01%
GIRARD PARTNERS LTD. 66,081$162,0000.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders